Results 1 to 10 of about 27,196 (164)
Anais Brasileiros De Dermatologia, 2023 Cutaneous lupus erythematosus is an autoimmune disease of varied clinical expression, which may present as an exclusively cutaneous disease or be one of the multiple manifestations of systemic lupus erythematosus.
Everton Carlos Siviero Do Vale +1 more
exaly +3 more sources
A Systematic Review of the Progression of Cutaneous Lupus to Systemic Lupus Erythematosus
Frontiers in Immunology, 2022 Lupus erythematosus is an autoimmune disease that may manifest in a variety of organs and tissues including the skin, kidney, brain, heart and lung. Many patients present with cutaneous lupus, where disease is often limited to the skin, but are at risk ...
Amanda M Walker +2 more
exaly +3 more sources
The First Case of Linear Cutaneous Lupus Erythematosus Following Covid‐19 Vaccination: A Case Report [PDF]
Clinical Case ReportsLinear cutaneous discoid lupus erythematosus (LCDLE) is a rare presentation of lupus erythematosus, more frequently observed in children and young adults.
Fatemeh Saberi +5 more
doaj +2 more sources
Cutaneous lupus erythematosus: An update
Indian Dermatology Online Journal, 2014 Lupus erythematosus (LE) is a chronic, autoimmune, multisystem disease that displays many diverse symptoms in which localized cutaneous LE (CLE) is on one end of the spectrum and severe systemic LE (SLE) on the other end.
Carina M Grönhagen, Filippa Nyberg
doaj +3 more sources
Skin involvement in systemic lupus erythematosus: a review article [PDF]
Romanian Journal of Rheumatology, 2023 Cutaneous disease is one of the most frequent manifestations of systemic lupus erythematosus (SLE), being classified as LE-specific and LE-nonspecific.
Teodora Baciu +7 more
doaj +1 more source
Lupus Science and Medicine, 2023 Objective Lupus erythematosus (LE) is a complicated disease with highly heterogeneous clinical manifestations. Previous studies have rarely included all subgroups of patients with lupus and have overlooked the importance of the cutaneous manifestations ...
Qing Zhang +19 more
doaj +1 more source
Lupus Science and Medicine, 2023 Objective To assess the efficacy of anifrolumab, a type-1 interferon receptor subunit-1 monoclonal antibody, in treating refractory cutaneous lupus erythematosus (CLE) and lupus non-specific mucocutaneous manifestations in patients with systemic lupus ...
Jun Kang, Aaron Bao
doaj +1 more source
Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects [PDF]
Anais Brasileiros de Dermatologia, 2014 Systemic Lupus Erythematosus is a chronic inflammatory disease with multifactorial etiology. Although clinical manifestations are varied, the skin is an important target-organ, which contributes to the inclusion of skin lesions in 4 out of the 17 new ...
Jucelio Pereira Moura Filho +6 more
doaj +1 more source
Acta Dermato-Venereologica, 2022 NLRP3 inflammasome is suggested to contribute to the complex pathogenesis of systemic lupus erythematosus, but its role in cutaneous lupus erythematosus has not been addressed.
Katariina Mähönen +6 more
doaj +1 more source
Ocular discoid lupus erythematosus: More than what meets the eye
Indian Dermatology Online Journal, 2023 Lupus erythematosus is a spectrum that includes auto-immune disorders such as systemic lupus erythematosus (SLE), subacute cutaneous lupus erythematosus (SCLE), and chronic cutaneous lupus erythematosus (CCLE).
Sumiti Pareek +3 more
doaj +1 more source